Company intelligence

IKT

Inhibikase Therapeutics, Inc. · NASDAQ · Healthcare

Price$2.34+0.43% · +$0.01

Market cap308.96MEquity value

P / E-5.4Trailing ratio

Volume303.19KLatest session

Market data

IKT price chart

TradingView

Related signals

1 min delayed

Browse public IKT signals with their source context and measured market impact. Open any signal for its permanent analysis page.

IKTJan 29, 2025-31.43% since signal

Inhibikase halts Parkinson's drug due to ineffective trial results. Study showed no improvement in daily task performance for patients.

Research